Brand Name | Status | Last Update |
---|---|---|
dimethyl fumarate | ANDA | 2024-12-23 |
dimethyl fumarate dimethyl fumarate | ANDA | 2025-04-01 |
tecfidera | New Drug Application | 2024-03-14 |
Expiration | Code | ||
---|---|---|---|
DIMETHYL FUMARATE, TECFIDERA, BIOGEN INC | |||
2023-02-05 | M-260 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple sclerosis | D009103 | EFO_0003885 | G35 | 2 | 5 | 14 | 16 | 17 | 54 |
Sclerosis | D012598 | — | — | 2 | 5 | 14 | 12 | 14 | 47 |
Relapsing-remitting multiple sclerosis | D020529 | EFO_0003929 | — | 1 | 2 | 12 | 9 | 6 | 30 |
Flushing | D005483 | — | R23.2 | — | — | 1 | 1 | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 8 | — | 1 | — | — | 9 |
Chronic progressive multiple sclerosis | D020528 | EFO_0003840 | — | — | 1 | 1 | — | — | 2 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Arthritis | D001168 | EFO_0005856 | M05-M14 | — | 1 | — | — | 1 | 2 |
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypertension | D006973 | EFO_0000537 | I10 | 1 | — | — | — | — | 1 |
Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | 1 | — | — | — | — | 1 |
Systemic scleroderma | D012595 | EFO_0000717 | M34 | 1 | — | — | — | — | 1 |
Pulmonary arterial hypertension | D000081029 | — | — | 1 | — | — | — | — | 1 |
Diffuse scleroderma | D045743 | EFO_0000404 | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Psoriatic arthritis | D015535 | EFO_0003778 | L40.5 | — | — | — | — | 1 | 1 |
Psoriasis | D011565 | EFO_0000676 | L40 | — | — | — | — | 1 | 1 |
Lymphopenia | D008231 | — | D72.810 | — | — | — | — | 1 | 1 |
Leukoencephalopathies | D056784 | — | R90.82 | — | — | — | — | 1 | 1 |
Progressive multifocal leukoencephalopathy | D007968 | EFO_0007455 | A81.2 | — | — | — | — | 1 | 1 |
Drug common name | Dimethyl fumarate |
INN | — |
Description | Dimethyl fumarate is an enoate ester resulting from the formal condensation of both carboxy groups of fumaric acid with methanol. Used for treatment of adults with relapsing forms of multiple sclerosis. It has a role as an immunomodulator and an antipsoriatic. It is an enoate ester, a methyl ester and a diester. It is functionally related to a methanol and a fumaric acid. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | COC(=O)/C=C/C(=O)OC |
PDB | — |
CAS-ID | 624-49-7 |
RxCUI | — |
ChEMBL ID | CHEMBL2107333 |
ChEBI ID | 76004 |
PubChem CID | 637568 |
DrugBank | DB08908 |
UNII ID | — |